Physician profile
James E Flores
NPI 1568502813
$2,317.30
in general payments reported to CMS, 2019-2025
19 companies · $691 in 2025
The $691 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2022: $173 · 2023: $310 · 2024: $911 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,911.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $517.90 | 2024-2025 | Xiidra, Miebo, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $372.08 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $333.12 | 2023-2025 | Hydrus Microstent, Rocklatan, Argos |
| Oyster Point Pharma, INC. | $153.22 | 2023-2024 | Tyrvaya |
| Allergan, INC. | $140.54 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $123.07 | 2024-2025 | Acthar |
| Glaukos Corporation | $86.93 | 2025 | Idosetr |
| Rxsight INC | $84.03 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Sun Pharmaceutical Industries INC. | $80.91 | 2019-2024 | |
| Horizon Therapeutics Plc | $78.92 | 2023 | Uplizna |
| Kala Pharmaceuticals, INC. | $74.61 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $64.70 | 2019-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $63.24 | 2019 | |
| Amgen INC. | $45.75 | 2024-2025 | Tepezza |
| Mallinckrodt Enterprises LLC | $34.02 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $19.90 | 2019 | |
| Sight Sciences, INC. | $17.95 | 2025 | Omni Surgical System |
| Shire North American Group INC | $15.00 | 2019 | |
| Lensar, INC. | $11.41 | 2024 | Lensar Laser System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Flores listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.